Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CETP | P11597 | 20/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6282061 | 0.93 | CETP (0.75) | CETP | |
| SCHEMBL5179946 | 0.90 | CETP (0.74) | CETP | |
| SCHEMBL6743623 | 0.88 | CETP (0.70) | CETP | |
| SCHEMBL7649062 | 0.87 | CETP (0.70) | CETP | |
| SCHEMBL3278131 | 0.87 | CETP (0.80) | CETP | |
| SCHEMBL5179676 | 0.87 | CETP (0.80) | CETP | |
| SCHEMBL3278134 | 0.87 | CETP (0.80) | CETP | |
| SCHEMBL993489 | 0.87 | CETP (0.94) | CETP | |
| SCHEMBL992448 | 0.87 | CETP (0.94) | CETP | |
| SCHEMBL1565490 | 0.86 | CETP (0.79) | CETP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12615656-B2 | Enhanced Wideband High Frequency (HF) data transmission with adaptive interference avoidance | NXM NETWORKS INC. (US) | 2026-04-28 | — | — | US | disclosed |
| US-20230041870-A1 | Enhanced Wideband High Frequency (HF) Data Transmission with Adaptive Interference Avoidance | NXM NETWORKS INC. | 2023-02-09 | — | — | US | disclosed |
| WO-2023014836-A2 | ENHANCED WIDEBAND HIGH FREQUENCY (HF) DATA TRANSMISSION WITH ADAPTIVE INTERFERENCE AVOIDANCE | NXM NETWORKS INC. (US) | 2023-02-09 | — | — | WO | disclosed |
| WO-2005117869-A1 | COMBINATIONS COMPRISING (S)-AMLODIPINE AND A CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR, AND METHODS FOR REDUCING HYPERTENSION | SEPRACOR INC. (US) | 2005-12-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12615656-B2 | Enhanced Wideband High Frequency (HF) data transmission with adaptive interference avoidance | SFRP1, FZD7, FOSB | CETP 4697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.